BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27127202)

  • 1. Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor.
    Witkowski M; Weithauser A; Tabaraie T; Steffens D; Kränkel N; Witkowski M; Stratmann B; Tschoepe D; Landmesser U; Rauch-Kroehnert U
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1263-71. PubMed ID: 27127202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes.
    Witkowski M; Tabaraie T; Steffens D; Friebel J; Dörner A; Skurk C; Witkowski M; Stratmann B; Tschoepe D; Landmesser U; Rauch U
    Cardiovasc Diabetol; 2018 Feb; 17(1):34. PubMed ID: 29477147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes.
    Witkowski M; Witkowski M; Saffarzadeh M; Friebel J; Tabaraie T; Ta Bao L; Chakraborty A; Dörner A; Stratmann B; Tschoepe D; Winter SJ; Krueger A; Ruf W; Landmesser U; Rauch U
    Cardiovasc Diabetol; 2020 Feb; 19(1):20. PubMed ID: 32066445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-223 inhibits tissue factor expression in vascular endothelial cells.
    Li S; Chen H; Ren J; Geng Q; Song J; Lee C; Cao C; Zhang J; Xu N
    Atherosclerosis; 2014 Dec; 237(2):514-20. PubMed ID: 25463083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
    Breitenstein A; Stein S; Holy EW; Camici GG; Lohmann C; Akhmedov A; Spescha R; Elliott PJ; Westphal CH; Matter CM; Lüscher TF; Tanner FC
    Cardiovasc Res; 2011 Feb; 89(2):464-72. PubMed ID: 20978007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes.
    Witkowski M; Friebel J; Tabaraie T; Grabitz S; Dörner A; Taghipour L; Jakobs K; Stratmann B; Tschoepe D; Landmesser U; Rauch U
    Cardiovasc Drugs Ther; 2021 Aug; 35(4):809-813. PubMed ID: 32940892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor.
    Li S; Ren J; Xu N; Zhang J; Geng Q; Cao C; Lee C; Song J; Li J; Chen H
    J Mol Cell Cardiol; 2014 Oct; 75():49-57. PubMed ID: 24998411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low thrombogenicity of calcified atherosclerotic plaques is associated with bone morphogenetic protein-2-dependent inhibition of tissue factor expression.
    Egorina EM; Sovershaev MA; Bogdanov VY; Sovershaev TA; Fallon JT; Seredkina N; Østerud B; Hansen JB
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):642-50. PubMed ID: 21897206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein -7 increases thrombogenicity of lipid-rich atherosclerotic plaques via activation of tissue factor.
    Sovershaev MA; Egorina EM; Bogdanov VY; Seredkina N; Fallon JT; Valkov AY; Østerud B; Hansen JB
    Thromb Res; 2010 Oct; 126(4):306-10. PubMed ID: 20656331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-145 Impedes Thrombus Formation via Targeting Tissue Factor in Venous Thrombosis.
    Sahu A; Jha PK; Prabhakar A; Singh HD; Gupta N; Chatterjee T; Tyagi T; Sharma S; Kumari B; Singh S; Nair V; Goel S; Ashraf MZ
    EBioMedicine; 2017 Dec; 26():175-186. PubMed ID: 29217135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.
    Basavaraj MG; Gruber FX; Sovershaev M; Appelbom HI; Osterud B; Petersen LC; Hansen JB
    Thromb Res; 2010 Nov; 126(5):418-25. PubMed ID: 20723970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-borne tissue factor activity predicts major cerebrovascular events in patients undergoing carotid endarterectomy: results from a 1-year follow-up study.
    Krupinski J; Turu MM; Font MA; Catena E; Slevin M; Morchon S; Rubio F; Badimon L; Martínez-González J
    Cerebrovasc Dis; 2008; 25(1-2):32-9. PubMed ID: 18033956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of tissue factor in endothelial cells induces cell apoptosis, mediated through p38 and p53 activation.
    ElKeeb AM; Collier ME; Maraveyas A; Ettelaie C
    Thromb Haemost; 2015 Aug; 114(2):364-78. PubMed ID: 25903973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-181c restrains nitration stress of endothelial cells in diabetic db/db mice through inhibiting the expression of FoxO1.
    Yang G; Wu Y; Ye S
    Biochem Biophys Res Commun; 2017 Apr; 486(1):29-35. PubMed ID: 28223216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species.
    Niiya Y; Abumiya T; Shichinohe H; Kuroda S; Kikuchi S; Ieko M; Yamagishi S; Takeuchi M; Sato T; Iwasaki Y
    Brain Res; 2006 Sep; 1108(1):179-87. PubMed ID: 16872585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus.
    Jansen F; Wang H; Przybilla D; Franklin BS; Dolf A; Pfeifer P; Schmitz T; Flender A; Endl E; Nickenig G; Werner N
    Cardiovasc Diabetol; 2016 Mar; 15():49. PubMed ID: 27005938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine induces endothelial tissue factor expression via phosphatidylinositol 3-kinase inhibition.
    Gebhard C; Holy EW; Camici GG; Akhmedov A; Stämpfli SF; Stähli BE; von Rickenbach B; Breitenstein A; Greutert H; Yang Z; Lüscher TF; Tanner FC
    Thromb Haemost; 2012 May; 107(5):884-94. PubMed ID: 22437887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP-7 induces TF expression in human monocytes by increasing F3 transcriptional activity.
    Sovershaev TA; Egorina EM; Unruh D; Bogdanov VY; Hansen JB; Sovershaev MA
    Thromb Res; 2015 Feb; 135(2):398-403. PubMed ID: 25533127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor expression in obese type 2 diabetic subjects and its regulation by antidiabetic agents.
    Wang J; Ciaraldi TP; Samad F
    J Obes; 2015; 2015():291209. PubMed ID: 25861467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Expression of microRNA-223 and FAM5C in Cerebral Infarction Patients with Diabetes Mellitus.
    Long Y; Zhan Q; Yuan M; Duan X; Zhou J; Lu J; Li Z; Yu F; Zhou X; Yang Q; Xia J
    Cardiovasc Toxicol; 2017 Jan; 17(1):42-48. PubMed ID: 26717922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.